EPSTEIN BARR VIRUS (EBV), QUANTITATIVE PCR
MRP - ₹ 6,700
What is a EPSTEIN BARR VIRUS (EBV), QUANTITATIVE PCR?
The Epstein Barr Virus (EBV) Quantitative PCR test is a molecular diagnostic test that measures the amount of EBV DNA present in a patient’s blood. EBV is linked to infectious mononucleosis and certain cancers, and monitoring viral load is crucial in immunocompromised patients, such as transplant recipients. This test helps clinicians assess active infection, track disease progression, and evaluate treatment response. By providing precise viral counts, it guides timely medical decisions and supports effective patient management.
Additional Information
| Also known as/ Other names: | EBV Quantitative PCR, Epstein-Barr Virus Viral Load Test, EBV DNA Quantitative PCR, EBV Viral Load Assay |
| Parameters: | 1 |
| Recommended for: | M/F/Others |
| Sample Type: | Blood |
| Patient Preparation: | No prior preparation is needed |
| Reports: | Wednesday & Saturday |
FAQs
High EBV DNA levels suggest active infection or reactivation, requiring medical evaluation.
Low levels may indicate controlled infection or effective treatment response.
Patients with suspected EBV infection, transplant recipients, or immunocompromised individuals benefit from this test.
Yes, PCR is highly sensitive and can detect EBV DNA during early infection stages.
Certainly, quantitative results help track viral load changes over time, showing whether therapy is working.
Yes, it confirms EBV DNA presence, but doctors may order additional tests to assess severity.
Yes, EBV is linked to certain cancers like Burkitt’s lymphoma and nasopharyngeal carcinoma.
Yes, it is safe and may help detect EBV infection that could affect maternal health.